ONO Kenjiro

Last updated: Nov 8, 2018 at 12:43

Name	ONO Kenjiro
Affiliation	Showa University
Section	Hospital, Hospital, Neurology
Research funding number	70377381

Published Papers

Plain Text

Alzheimer's disease as oligomeropathy.

Ono K

Neurochemistry international 119 57-70 Oct 2018 [Refereed]

Cerebrospinal fluid 5-HIAA concentrations correlate with cardiac uptake of ¹²³I-MIBG during myocardial scintigraphy in drug naïve Parkinson's disease.

Murakami H, Yamamoto K, Yasumoto T, Kimura A, Sakae Y, Nomoto S, Kubota S, Watanabe D, Watanabe K, Saito Y, Yano S, Ono K

Journal of neural transmission (Vienna, Austria : 1996) 125(10) 1511-1514 Oct 2018 [Refereed]

The Cerebellar Leptomeningeal Enhancement Associated with Cryptococcal Meningitis.

Shiromaru A, Kinno R, Ito N, Ono K

Internal medicine (Tokyo, Japan) Aug 2018 [Refereed]

Japanese multicenter database of healthy controls for [¹²³I]FP-CIT SPECT.

Matsuda H, Murata M, Mukai Y, Sako K, Ono H, Toyama H, Inui Y, Taki Y, Shimomura H, Nagayama H, Tateno A, Ono K, Murakami H, Kono A, Hirano S, Kuwabara S, Maikusa N, Ogawa M, Imabayashi E, Sato N, Takano H, Hatazawa J, Takahashi R

European journal of nuclear medicine and molecular imaging 45(8) 1405-1416 Jul 2018 [Refereed]

New mode of burst spinal cord stimulation improved mental status as well as motor function in a patient with Parkinson's disease.

Kobayashi R, Kenji S, Taketomi A, Murakami H, Ono K, Otake H

Parkinsonism & related disorders Jul 2018 [Refereed]

Supratherapeutic concentrations of cilostazol inhibits β-amyloid oligomerization in vitro.

Shozawa H, Oguchi T, Tsuji M, Yano S, Kiuchi Y, Ono K

Neuroscience letters 677 19-25 Jun 2018 [Refereed]

Agraphia of the left hand with dysfunction of the left superior parietal region without callosal lesions.

Kinno R, Ohashi H, Mori Y, Shiromaru A, Ono K

eNeurologicalSci 10 16-18 Mar 2018 [Refereed]

Time-series analysis: variation of anti-acetylcholine receptor antibody titer in myasthenia gravis is related to incidence of Mycoplasma pneumoniae and influenza virus infections.

Iwasa K, Yoshikawa H, Hamaguchi T, Sakai K, Shinohara-Noguchi M, Samuraki M, Takahashi K, Yanase D, Ono K, Ishida C, Yoshita M, Nakamura H, Yamada M

Neurological research 40(2) 102-109 Feb 2018 [Refereed]

Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer's disease-type beta-amyloid neuropathological mechanisms.

Ho L, Ono K, Tsuji M, Mazzola P, Singh R, Pasinetti GM

Expert review of neurotherapeutics 18(1) 83-90 Jan 2018 [Refereed]

Singular case of the driving instructor: Temporal and topographical disorientation.

Futamura A, Honma M, Shiromaru A, Kuroda T, Masaoka Y, Midorikawa A, Miller MW, Kawamura M, Ono K

Neurology and clinical neuroscience 6(1) 16-18 Jan 2018 [Refereed]

Left Posterior Orbitofrontal Cortex Is Associated With Odor-Induced Autobiographical Memory: An fMRI Study.

Watanabe K, Masaoka Y, Kawamura M, Yoshida M, Koiwa N, Yoshikawa A, Kubota S, Ida M, Ono K, Izumizaki M

Frontiers in psychology 9 687 2018 [Refereed]

High-Speed Atomic Force Microscopy of Individual Amyloidogenic Protein Assemblies.

Watanabe-Nakayama T, Ono K

Methods in molecular biology (Clifton, N.J.) 1814 201-212 2018 [Refereed]

Diagonistic Apraxia: A Unique Case of Corpus Callosal Disconnection Syndrome and Neuromyelitis Optica Spectrum Disorder.

Shozawa H, Futamura A, Saito Y, Honma M, Kawamura M, Miller MW, Ono K

Frontiers in neurology 9 653 2018 [Refereed]

The Oligomer Hypothesis in α-Synucleinopathy.

Ono K

Neurochemical research 42(12) 3362-3371 Dec 2017 [Refereed]

Elevated Serum High-Mobility Group Box-1 Protein Level Is Associated with Poor Functional Outcome in Ischemic Stroke.

Tsukagawa T, Katsumata R, Fujita M, Yasui K, Akhoon C, Ono K, Dohi K, Aruga T

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 26(10) 2404-2411 Oct 2017 [Refereed]

Coexistence of transthyretin- and Aβ-type cerebral amyloid angiopathy in a patient with hereditary transthyretin V30M amyloidosis.

Sakai K, Asakawa M, Takahashi R, Ishida C, Nakamura R, Hamaguchi T, Ono K, Iwasa K, Yamada M

Journal of the neurological sciences 381 144-146 Oct 2017 [Refereed]

[Characteristics of Geriatric Epilepsy Can Include Dementia].

Ishigaki S, Kawamura M, Ono K

Brain and nerve = Shinkei kenkyu no shinpo 69(10) 1125-1130 Oct 2017 [Refereed]

[Clocks, Behavior, and Cognition].

Futamura A, Shiromaru A, Kuroda T, Honma M, Kinno R, Ono K, Kawamura M

Brain and nerve = Shinkei kenkyu no shinpo 69(6) 639-649 Jun 2017 [Refereed]

Granuloma formation in a patient with GNE myopathy: A case report.

Nakamura K, Hamaguchi T, Sakai K, Noto D, Ono K, Hayashi Y, Nishino I, Yamada M

Neuromuscular disorders : NMD 27(2) 183-184 Feb 2017 [Refereed]

[MELAS: Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes].

Murakami H, Ono K

Brain and nerve = Shinkei kenkyu no shinpo 69(2) 111-117 Feb 2017 [Refereed]

Tocotrienol-Rich Fraction Modulates Amyloid Pathology and Improves Cognitive Function in AβPP/PS1 Mice.

Ibrahim NF, Yanagisawa D, Durani LW, Hamezah HS, Damanhuri HA, Wan Ngah WZ, Tsuji M, Kiuchi Y, Ono K, Tooyama I

Journal of Alzheimer's disease : JAD 55(2) 597-612 2017 [Refereed]

Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.

Noguchi-Shinohara M, Komatsu J, Samuraki M, Matsunari I, Ikeda T, Sakai K, Hamaguchi T, Ono K, Nakamura H, Yamada M

Journal of Alzheimer's disease : JAD 55(3) 905-913 2017 [Refereed]

Accumulation of ¹²³I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson's Disease.

Murakami H, Nohara T, Uchiyama M, Owan Y, Futamura A, Shiromaru A, Tsukada S, Saito Y, Kuroda T, Yano S, Ishigaki S, Katoh H, Munechika J, Ohgiya Y, Gokan T, Ono K

Frontiers in aging neuroscience 9 321 2017 [Refereed]

Cilostazol Suppresses Aβ-induced Neurotoxicity in SH-SY5Y Cells through Inhibition of Oxidative Stress and MAPK Signaling Pathway.

Oguchi T, Ono R, Tsuji M, Shozawa H, Somei M, Inagaki M, Mori Y, Yasumoto T, Ono K, Kiuchi Y

Frontiers in aging neuroscience 9 337 2017 [Refereed]

Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson's disease.

Murakami H, Nohara T, Shozawa H, Owan Y, Kuroda T, Yano S, Kezuka M, Kawamura M, Ono K

Neuropsychiatric disease and treatment 13 2719-2726 2017 [Refereed]

Differential Effects of the Factor Structure of the Wechsler Memory Scale-Revised on the Cortical Thickness and Complexity of Patients Aged Over 75 Years in a Memory Clinic Setting.

Kinno R, Shiromaru A, Mori Y, Futamura A, Kuroda T, Yano S, Murakami H, Ono K

Frontiers in aging neuroscience 9 405 2017 [Refereed]

Efficacy of levetiracetam in primary hemifacial spasm.

Kuroda T, Saito Y, Fujita K, Yano S, Ishigaki S, Kato H, Murakami H, Ono K

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 34 213-215 Dec 2016 [Refereed]

Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.

Umeda T, Ono K, Sakai A, Yamashita M, Mizuguchi M, Klein WL, Yamada M, Mori H, Tomiyama T

Brain : a journal of neurology 139(Pt 5) 1568-1586 May 2016 [Refereed]

High-speed atomic force microscopy reveals structural dynamics of amyloid β1-42 aggregates.

Watanabe-Nakayama T, Ono K, Itami M, Takahashi R, Teplow DB, Yamada M

Proceedings of the National Academy of Sciences of the United States of America 113(21) 5835-5840 May 2016 [Refereed]

Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson's Disease Patients Taking Dopaminergic Medication.

Murakami H, Momma Y, Nohara T, Mori Y, Futamura A, Sugita T, Ishigaki S, Katoh H, Kezuka M, Ono K, Miller MW, Kawamura M

Journal of Parkinson's disease 6(1) 209-217 2016 [Refereed]

Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.

Takahashi R, Ono K, Takamura Y, Mizuguchi M, Ikeda T, Nishijo H, Yamada M

Journal of neurochemistry 134(5) 943-955 Sep 2015 [Refereed]

Inclusion body myositis with granuloma formation in muscle tissue.

Sakai K, Ikeda Y, Ishida C, Matsumoto Y, Ono K, Iwasa K, Yamada M

Neuromuscular disorders : NMD 25(9) 706-712 Sep 2015 [Refereed]

Exacerbation of myasthenia gravis by intravenous peramivir.

Hayashi K, Iwasa K, Morinaga A, Ono K, Yamada M

Muscle & nerve 51(6) 935-936 Jun 2015 [Refereed]

Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer's disease β-amyloid oligomerization.

Wang D, Ho L, Faith J, Ono K, Janle EM, Lachcik PJ, Cooper BR, Jannasch AH, D'Arcy BR, Williams BA, Ferruzzi MG, Levine S, Zhao W, Dubner L, Pasinetti GM

Molecular nutrition & food research 59(6) 1025-1040 Jun 2015 [Refereed]

Pharmacokinetics, Safety and Tolerability of Melissa officinalis Extract which Contained Rosmarinic Acid in Healthy Individuals: A Randomized Controlled Trial.

Noguchi-Shinohara M, Ono K, Hamaguchi T, Iwasa K, Nagai T, Kobayashi S, Nakamura H, Yamada M

PloS one 10(5) e0126422 2015 [Refereed]

Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis.

Yamada M, Ono K, Hamaguchi T, Noguchi-Shinohara M

Advances in experimental medicine and biology 863 79-94 2015 [Refereed]

Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.

Samuraki M, Matsunari I, Yoshita M, Shima K, Noguchi-Shinohara M, Hamaguchi T, Ono K, Yamada M

Journal of Alzheimer's disease : JAD 48(2) 517-528 2015 [Refereed]

Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area.

Takahashi R, Ono K, Shibata S, Nakamura K, Komatsu J, Ikeda Y, Ikeda T, Samuraki M, Sakai K, Iwasa K, Kayano D, Yamada M

Journal of the neurological sciences 345(1-2) 231-235 Oct 2014 [Refereed]

Neurolymphomatosis exhibiting repeated exacerbation and remission in both the peripheral and central nervous systems.

Akagi A, Ono K, Hamaguchi T, Samuraki M, Nakada M, Shima Y, Oohata T, Yamada M

Journal of the neurological sciences 345(1-2) 267-268 Oct 2014 [Refereed]

Exogenous amyloidogenic proteins function as seeds in amyloid β-protein aggregation.

Ono K, Takahashi R, Ikeda T, Mizuguchi M, Hamaguchi T, Yamada M

Biochimica et biophysica acta 1842(4) 646-653 Apr 2014 [Refereed]

Effects of the neurotrophic agent T-817MA on oligomeric amyloid-β-induced deficits in long-term potentiation in the hippocampal CA1 subfield.

Takamura Y, Ono K, Matsumoto J, Yamada M, Nishijo H

Neurobiology of aging 35(3) 532-536 Mar 2014 [Refereed]

[Alpha-Synuclein in blood and cerebrospinal fluid of patients with alpha-synucleinopathy].

Ono K, Yamada M

Rinsho byori. The Japanese journal of clinical pathology 62(3) 241-245 Mar 2014 [Refereed]

Myasthenia gravis: predictive factors associated with the synchronized elevation of anti-acetylcholine receptor antibody titer in Kanazawa, Japan.

Iwasa K, Yoshikawa H, Samuraki M, Shinohara M, Hamaguchi T, Ono K, Nakamura H, Yamada M

Journal of neuroimmunology 267(1-2) 97-101 Feb 2014 [Refereed]

Molecular topology as novel strategy for discovery of drugs with aβ lowering and anti-aggregation dual activities for Alzheimer's disease.

Wang J, Land D, Ono K, Galvez J, Zhao W, Vempati P, Steele JW, Cheng A, Yamada M, Levine S, Mazzola P, Pasinetti GM

PloS one 9(3) e92750 2014 [Refereed]

Cocoa extracts reduce oligomerization of amyloid-β: implications for cognitive improvement in Alzheimer's disease.

Wang J, Varghese M, Ono K, Yamada M, Levine S, Tzavaras N, Gong B, Hurst WJ, Blitzer RD, Pasinetti GM

Journal of Alzheimer's disease : JAD 41(2) 643-650 2014 [Refereed]

Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro.

Ono K, Takasaki J, Takahashi R, Ikeda T, Yamada M

Journal of neuroscience research 91(10) 1371-1381 Oct 2013 [Refereed]

Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models.

Gong B, Pan Y, Vempati P, Zhao W, Knable L, Ho L, Wang J, Sastre M, Ono K, Sauve AA, Pasinetti GM

Neurobiology of aging 34(6) 1581-1588 Jun 2013 [Refereed]

Unintended effects of cardiovascular drugs on the pathogenesis of Alzheimer's disease.

Wang J, Zhao Z, Lin E, Zhao W, Qian X, Freire D, Bilski AE, Cheng A, Vempati P, Ho L, Ono K, Yamada M, Pasinetti GM

PloS one 8(6) e65232 2013 [Refereed]

[Α-synuclein as a biomarker for early diagnosis of Parkinsonism].

Ono K, Yamada M

Rinsho shinkeigaku = Clinical neurology 53(11) 983-985 2013 [Refereed]

Posterior cingulate atrophy and metabolic decline in early stage Alzheimer's disease.

Shima K, Matsunari I, Samuraki M, Chen WP, Yanase D, Noguchi-Shinohara M, Takeda N, Ono K, Yoshita M, Miyazaki Y, Matsuda H, Yamada M

Neurobiology of aging 33(9) 2006-2017 Sep 2012 [Refereed]

Effect of melatonin on α-synuclein self-assembly and cytotoxicity.

Ono K, Mochizuki H, Ikeda T, Nihira T, Takasaki J, Teplow DB, Yamada M

Neurobiology of aging 33(9) 2172-2185 Sep 2012 [Refereed]

Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy.

Takahashi R, Ono K, Ikeda T, Akagi A, Noto D, Nozaki I, Sakai K, Asakura H, Iwasa K, Yamada M

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 19(3) 129-132 Sep 2012 [Refereed]

Cross-seeding effects of amyloid β-protein and α-synuclein.

Ono K, Takahashi R, Ikeda T, Yamada M

Journal of neurochemistry 122(5) 883-890 Sep 2012 [Refereed]

Anti-amyloidogenic effects of soybean isoflavones in vitro: Fluorescence spectroscopy demonstrating direct binding to Aβ monomers, oligomers and fibrils.

Hirohata M, Ono K, Takasaki J, Takahashi R, Ikeda T, Morinaga A, Yamada M

Biochimica et biophysica acta 1822(8) 1316-1324 Aug 2012 [Refereed]

Parkinson's disease showing progressive conduction aphasia.

Sakai K, Ono K, Harada H, Shima K, Notoya M, Yamada M

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 33(2) 399-402 Apr 2012 [Refereed]

Vitamin A and Alzheimer's disease.

Ono K, Yamada M

Geriatrics & gerontology international 12(2) 180-188 Apr 2012 [Refereed]

Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site-specific binding.

Ono K, Li L, Takamura Y, Yoshiike Y, Zhu L, Han F, Mao X, Ikeda T, Takasaki J, Nishijo H, Takashima A, Teplow DB, Zagorski MG, Yamada M

The Journal of biological chemistry 287(18) 14631-14643 Apr 2012 [Refereed]

Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment.

Wang J, Ferruzzi MG, Ho L, Blount J, Janle EM, Gong B, Pan Y, Gowda GA, Raftery D, Arrieta-Cruz I, Sharma V, Cooper B, Lobo J, Simon JE, Zhang C, Cheng A, Qian X, Ono K, Teplow DB, Pavlides C, Dixon RA, Pasinetti GM

The Journal of neuroscience : the official journal of the Society for Neuroscience 32(15) 5144-5150 Apr 2012 [Refereed]

Preparation of stable amyloid β-protein oligomers of defined assembly order.

Rosensweig C, Ono K, Murakami K, Lowenstein DK, Bitan G, Teplow DB

Methods in molecular biology (Clifton, N.J.) 849 23-31 2012 [Refereed]

Carvedilol as a potential novel agent for the treatment of Alzheimer's disease.

Wang J, Ono K, Dickstein DL, Arrieta-Cruz I, Zhao W, Qian X, Lamparello A, Subnani R, Ferruzzi M, Pavlides C, Ho L, Hof PR, Teplow DB, Pasinetti GM

Neurobiology of aging 32(12) 2321.e1-12 Dec 2011 [Refereed]

Effect of an age-mismatched and sex-mismatched normal database on the diagnostic performance of ¹⁸F-FDG PET for Alzheimer's disease: the Ishikawa Brain Imaging Study.

Chen WP, Samuraki M, Shima K, Yanase D, Takeda N, Miyazaki Y, Ono K, Yoshita M, Nishimura S, Yamada M, Matsunari I

Nuclear medicine communications 32(12) 1128-1133 Dec 2011 [Refereed]

Imaging findings of familial dementia with a tau R406W mutation.

Komatsu J, Ono K, Yanase D, Samuraki M, Shima K, Kuwano R, Matsunari I, Yamada M

Acta neurologica Belgica 111(4) 374-375 Dec 2011 [Refereed]

Familial Parkinson disease mutations influence α-synuclein assembly.

Ono K, Ikeda T, Takasaki J, Yamada M

Neurobiology of disease 43(3) 715-724 Sep 2011 [Refereed]

Cervical flexion myelopathy in a patient showing apparent long tract signs: a severe form of Hirayama disease.

Sakai K, Ono K, Okamoto Y, Murakami H, Yamada M

Joint, bone, spine : revue du rhumatisme 78(3) 316-318 May 2011 [Refereed]

Low-n oligomers as therapeutic targets of Alzheimer's disease.

Ono K, Yamada M

Journal of neurochemistry 117(1) 19-28 Apr 2011 [Refereed]

Effects of sex hormones on Alzheimer's disease-associated β-amyloid oligomer formation in vitro.

Morinaga A, Ono K, Takasaki J, Ikeda T, Hirohata M, Yamada M

Experimental neurology 228(2) 298-302 Apr 2011 [Refereed]

Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro α-synuclein fibril formation.

Hirohata M, Ono K, Morinaga A, Ikeda T, Yamada M

Neuroscience letters 491(1) 48-52 Mar 2011 [Refereed]

Fisher syndrome associated with immune thrombocytopenic purpura.

Furukawa Y, Iwasa K, Ono K, Yamada M

Internal medicine (Tokyo, Japan) 50(6) 631-633 2011 [Refereed]

Vitamin A has anti-oligomerization effects on amyloid-β in vitro.

Takasaki J, Ono K, Yoshiike Y, Hirohata M, Ikeda T, Morinaga A, Takashima A, Yamada M

Journal of Alzheimer's disease : JAD 27(2) 271-280 2011 [Refereed]

REVIEW: Curcumin and Alzheimer's disease.

Hamaguchi T, Ono K, Yamada M

CNS neuroscience & therapeutics 16(5) 285-297 Oct 2010 [Refereed]

Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid beta-protein assembly and toxicity.

Ono K, Condron MM, Teplow DB

The Journal of biological chemistry 285(30) 23186-23197 Jul 2010 [Refereed]

[Search for antiamyloidogenic compounds based on a nucleation-dependent polymerization model].

Naiki H, Hasegawa K, Ono K, Yamada M

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 130(4) 503-509 Apr 2010 [Refereed]

CSF tau protein is a useful marker for effective treatment of superficial siderosis of the central nervous system: two case reports.

Ikeda T, Noto D, Noguchi-Shinohara M, Ono K, Takahashi K, Ishida C, Yoshita M, Kawaguchi M, Kawahara N, Iwasa K, Tomita K, Yamada M

Clinical neurology and neurosurgery 112(1) 62-64 Jan 2010 [Refereed]

Cerebrospinal Fluid from Alzheimer's disease patients promotes amyloid beta-protein oligomerization.

Ikeda T, Ono K, Elashoff D, Condron MM, Noguchi-Shinohara M, Yoshita M, Teplow DB, Yamada M

Journal of Alzheimer's disease : JAD 21(1) 81-86 2010 [Refereed]

Progression of cerebrovascular lesions in pneumococcal meningitis.

Sakai K, Ono K, Ohta K, Yamada M

Internal medicine (Tokyo, Japan) 49(12) 1261-1262 2010 [Refereed]

Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer's disease.

Wang J, Santa-Maria I, Ho L, Ksiezak-Reding H, Ono K, Teplow DB, Pasinetti GM

Journal of Alzheimer's disease : JAD 22(2) 653-661 2010 [Refereed]

A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.

Morinaga A, Ono K, Ikeda T, Ikeda Y, Shima K, Noguchi-Shinohara M, Samuraki M, Yanase D, Yoshita M, Iwasa K, Mastunari I, Yamada M

Dementia and geriatric cognitive disorders 30(4) 285-292 2010 [Refereed]

Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway.

Hamaguchi T, Ono K, Murase A, Yamada M

The American journal of pathology 175(6) 2557-2565 Dec 2009 [Refereed]

Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease.

Ono K, Yoshiike Y, Takashima A, Hasegawa K, Naiki H, Yamada M

Journal of neurochemistry 87(1) 172-181 Oct 2003 [Refereed]

Dyke-Davidoff-Masson syndrome manifested by seizure in late childhood: a case report.

Ono K, Komai K, Ikeda T

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 10(3) 367-371 May 2003 [Refereed]

Sensorimotor polyneuropathy with 5-aminosalicylic acid: a case report.

Ono K, Iwasa K, Shirasaki H, Takamori M

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 10(3) 386-389 May 2003 [Refereed]

Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro.

Ono K, Hasegawa K, Yamada M, Naiki H

Biological psychiatry 52(9) 880-886 Nov 2002 [Refereed]

Kinetic modeling and determination of reaction constants of Alzheimer's beta-amyloid fibril extension and dissociation using surface plasmon resonance.

Hasegawa K, Ono K, Yamada M, Naiki H

Biochemistry 41(46) 13489-13498 Nov 2002 [Refereed]

Myoclonic involuntary movement associated with chronic manganese poisoning.

Ono K, Komai K, Yamada M

Journal of the neurological sciences 199(1-2) 93-96 Jul 2002 [Refereed]

Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro.

Ono K, Hasegawa K, Yoshiike Y, Takashima A, Yamada M, Naiki H

Journal of neurochemistry 81(3) 434-440 May 2002 [Refereed]

Misc

Plain Text1 2 3 4 >

パーキンソン病の運動症状の評価における重心動揺計の有用性について

大湾喜行, 村上秀友, 馬場康彦, 小野賢二郎

パーキンソン病・運動障害疾患コングレスプログラム・抄録集 12回 89-89 Jul 2018

未投薬のParkinson病の脳脊髄液の5-HIAA濃度は心臓交感神経機能と関連する

村上秀友, 山本謙, 安本太郎, 木村篤史, 栄良樹, 野元祥平, 久保田怜美, 渡辺大士, 渡辺慶子, 齋藤悠, 小野賢二郎

パーキンソン病・運動障害疾患コングレスプログラム・抄録集 12回 92-92 Jul 2018

抗菌薬治療によりDATシンチ所見が改善した神経梅毒性パーキンソン症候群の66歳男性例

井藤尚仁, 四郎丸あずさ, 山本謙, 森友紀子, 二村明徳, 矢野怜, 村上秀友, 小野賢二郎

パーキンソン病・運動障害疾患コングレスプログラム・抄録集 12回 116-116 Jul 2018

【めまい・耳鳴りの診療のポイント】危険なめまい・耳鳴り

黒田岳志, 小野賢二郎

臨牀と研究 95(7) 773-777 Jul 2018

鎖骨下動脈狭窄の血管内治療にオトガイ下からの椎骨動脈超音波モニタリングを行った一例

小室浩康, 栗城綾子, 大橋英朗, 野原哲人, 水間啓太, 宮内淑史, 神谷雄己, 小野賢二郎

Neurosonology 31(増刊) 85-85 Jun 2018

Association Memberships

THE JAPAN STROKE SOCIETY(211) , JAPAN SOCIETY FOR DEMENTIA RESEARCH(190) , Society for Neuroscience(1011)

Research Grants & Projects

Plain Text

Development of preventive and therapeutic of Lewy body diseases

Patents

Plain Text

特願2004-381800

特開2005-104850

特願2006-007378